Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
173.12
+1.89 (1.10%)
May 27, 2025, 3:16 PM - Market open
Quest Diagnostics Stock Forecast
Stock Price Forecast
According to 14 professional analysts, the 12-month price target for Quest Diagnostics stock ranges from a low of $170 to a high of $200. The average analyst price target of $185.07 forecasts a 6.90% increase in the stock price over the next year.
Price Target: $185.07 (+6.90%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 2 | 3 | 3 |
Buy | 3 | 4 | 4 | 4 | 4 | 4 |
Hold | 7 | 6 | 6 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 14 | 14 | 13 | 14 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold Maintains $180 → $190 | Hold | Maintains | $180 → $190 | +9.75% | May 6, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $180 → $200 | Hold | Maintains | $180 → $200 | +15.53% | Apr 28, 2025 |
Truist Securities | Truist Securities | Hold Maintains $182 → $190 | Hold | Maintains | $182 → $190 | +9.75% | Apr 23, 2025 |
Barclays | Barclays | Hold Maintains $175 → $185 | Hold | Maintains | $175 → $185 | +6.86% | Apr 23, 2025 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $175 → $180 | Hold | Maintains | $175 → $180 | +3.97% | Apr 23, 2025 |
Financial Forecast
Revenue This Year
10.90B
from 9.87B
Increased by 10.38%
Revenue Next Year
11.34B
from 10.90B
Increased by 4.03%
EPS This Year
9.79
from 7.69
Increased by 27.37%
EPS Next Year
10.64
from 9.79
Increased by 8.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 11.4B | 12.0B | 12.6B | |
Avg | 10.9B | 11.3B | 11.8B | |
Low | 10.5B | 10.9B | 11.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 15.4% | 10.4% | 11.6% | |
Avg | 10.4% | 4.0% | 3.7% | |
Low | 6.1% | -0.1% | -0.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 10.25 | 11.36 | 12.30 | |
Avg | 9.79 | 10.64 | 11.47 | |
Low | 9.43 | 10.09 | 10.70 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 33.3% | 16.0% | 15.6% | |
Avg | 27.4% | 8.6% | 7.8% | |
Low | 22.6% | 3.1% | 0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.